Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 26875830)

Published in Nat Rev Immunol on February 15, 2016

Authors

Michel DuPage1, Jeffrey A Bluestone1

Author Affiliations

1: Diabetes Center and Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA.

Associated clinical trials:

Azacytidine During Anti-tuberculosis Therapy (AZA) | NCT03941496

Articles citing this

Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Proc Natl Acad Sci U S A (2016) 0.85

Azacytidine treatment inhibits the progression of Herpes Stromal Keratitis by enhancing regulatory T cell function. J Virol (2017) 0.79

The contribution of interleukin-2 to effective wound healing. Exp Biol Med (Maywood) (2016) 0.78

Therapeutic T cell engineering. Nature (2017) 0.77

Writ large: Genomic dissection of the effect of cellular environment on immune response. Science (2016) 0.76

Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFNγ+ Th1/Tregs. Circ Res (2016) 0.76

The protective effects of resveratrol on social stress-induced cytokine release and depressive-like behavior. Brain Behav Immun (2016) 0.76

Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection. Sci Rep (2016) 0.75

Novel benzoxazole derivatives DCPAB and HPAB attenuate Th1 cell-mediated inflammation through T-bet suppression. Sci Rep (2017) 0.75

An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition. JCI Insight (2017) 0.75

CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10. Front Immunol (2017) 0.75

Some vexations that challenge viral immunology. F1000Res (2016) 0.75

A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet. Clin Transl Med (2017) 0.75

Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging. Front Immunol (2016) 0.75

T-lymphocyte passive deformation is controlled by unfolding of membrane surface reservoirs. Mol Biol Cell (2016) 0.75

Neglected for too long? - CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells. J Clin Invest (2016) 0.75

CD4(+) T Cell Fate in Glomerulonephritis: A Tale of Th1, Th17, and Novel Treg Subtypes. Mediators Inflamm (2016) 0.75

Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells. J Immunol (2017) 0.75

Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases. Nat Rev Rheumatol (2017) 0.75

Notch Signaling in T Helper Cell Subsets: Instructor or Unbiased Amplifier? Front Immunol (2017) 0.75

Editorial: Tertiary Lymphoid Organs (TLOs): Powerhouses of Disease Immunity. Front Immunol (2017) 0.75

A Study of the Changes of T Helper 17 Cells and Regulatory T Cells in Herpes Zoster. Ann Dermatol (2017) 0.75

Control of Regulatory T Cell Differentiation by the Transcription Factors Thpok and LRF. J Immunol (2017) 0.75

Diverse continuum of CD4(+) T-cell states is determined by hierarchical additive integration of cytokine signals. Proc Natl Acad Sci U S A (2017) 0.75

Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation. J Immunol (2017) 0.75

Preparing Viable Single Cells from Human Tissue and Tumors for Cytomic Analysis. Curr Protoc Mol Biol (2017) 0.75

Molecular mechanisms underlying Th1-like Treg generation and function. Cell Mol Life Sci (2017) 0.75

Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity. PLoS One (2017) 0.75

Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression. Front Immunol (2017) 0.75

The function of regulatory T cells at the ocular surface: Review. Ocul Surf (2017) 0.75

Articles cited by this

(truncated to the top 100)

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41

Functional diversity of helper T lymphocytes. Nature (1996) 18.09

Dynamic regulation of nucleosome positioning in the human genome. Cell (2008) 15.60

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature (2008) 14.26

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity (2008) 10.26

Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity (2009) 9.73

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med (2002) 8.84

Late developmental plasticity in the T helper 17 lineage. Immunity (2009) 8.81

Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell (2009) 8.69

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol (2009) 8.65

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol (2009) 8.32

Plasticity of CD4+ T cell lineage differentiation. Immunity (2009) 8.08

The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity (2009) 6.86

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol (2008) 6.76

The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol (2009) 6.74

The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 6.65

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 6.45

Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell (2013) 6.30

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity (2008) 6.08

Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science (2010) 6.06

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med (2011) 5.99

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol (2007) 5.99

Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol (2011) 5.98

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A (2008) 5.97

Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol (2009) 5.72

Helper T cell differentiation is controlled by the cell cycle. Immunity (1998) 5.71

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell (2011) 5.63

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 5.47

Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity (1998) 5.38

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol (2011) 5.22

Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity (2009) 4.85

Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science (2009) 4.80

Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol (2011) 4.78

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest (2009) 4.74

T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med (2011) 4.71

T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol (2002) 4.38

Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol (2011) 4.29

Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A (2009) 4.25

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest (1991) 4.08

The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol (2010) 4.06

Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity (2010) 4.06

Control of TH17 cells occurs in the small intestine. Nature (2011) 4.03

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood (2008) 3.95

Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med (2013) 3.92

Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol (2009) 3.88

Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol (2003) 3.86

Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity (2001) 3.84

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (2012) 3.74

Fueling immunity: insights into metabolism and lymphocyte function. Science (2013) 3.62

The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol (2009) 3.44

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med (1996) 3.41

The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus. Cell (2013) 3.40

AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab (2012) 3.35

T follicular helper cell differentiation, function, and roles in disease. Immunity (2014) 3.29

Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell (2013) 3.22

TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol (2013) 3.18

Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol (2010) 3.12

Transcriptional regulation and its misregulation in disease. Cell (2013) 2.92

Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell (2012) 2.79

T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity (2012) 2.78

Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature (2012) 2.77

Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J Exp Med (2006) 2.69

T cell immunity. Functional heterogeneity of human memory CD4⁺ T cell clones primed by pathogens or vaccines. Science (2014) 2.69

An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol (2011) 2.69

Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med (2012) 2.62

Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity (2010) 2.59

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol (2004) 2.54

A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med (2010) 2.53

Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature (2015) 2.52

Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes (2008) 2.52

Selection of regulatory T cells in the thymus. Nat Rev Immunol (2012) 2.51

Bcl-6 directly represses the gene program of the glycolysis pathway. Nat Immunol (2014) 2.47

STATs shape the active enhancer landscape of T cell populations. Cell (2012) 2.45

Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity (2013) 2.41

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol (2011) 2.39

mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature (2013) 2.38

Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell (2013) 2.38

BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature (2013) 2.36

Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity. Cell (2015) 2.30

Profiles of lymphokine activities and helper function for IgE in human T cell clones. Eur J Immunol (1988) 2.28

Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol (2013) 2.24

Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol (2009) 2.21

TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med (2010) 2.20

Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov (2013) 2.16

The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity (2015) 2.16

Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med (2011) 2.14

The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat Immunol (2012) 2.14

De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med (2014) 2.13

Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood (2006) 2.12

Continuous requirement for the TCR in regulatory T cell function. Nat Immunol (2014) 2.11

Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat Biotechnol (2014) 2.10

The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab (2014) 2.06

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes (2012) 2.02

Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature (2013) 1.99

An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity (2013) 1.98

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature (2015) 1.98

Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J Exp Med (2008) 1.94

PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J Clin Invest (2006) 1.93

A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nat Immunol (2012) 1.93